Inventor · disambiguated record
Robert A. Kastelein
Also filed as: KASTELEIN ROBERT · KASTELEIN ROBERT A
68 granted patents·59 pending applications·798 citations·filing 1995–2025
99Inventor score
Files withSCHERING CORP53SYNTHEKINE INC32MERCK SHARP & DOHME14CHIRICA MADALINE3SCHERING CORP A NEW JERSEY COR3
Top patents by PatentIndex Score
127 records- 0198US6756481B2IL-23 receptor binding compositionsSCHERING CORP·Filed 2001·Granted Jun 29, 2004·103 cites·5 claims
- 0296US6562578B1IL-17-like cytokine binding compounds and antibodiesSCHERING CORP·Filed 2000·Granted May 13, 2003·63 cites·8 claims
- 0395US11873349B1Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 16, 2024·3 cites·6 claims
- 0494US7427402B2Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19SCHERING CORP·Filed 2006·Granted Sep 23, 2008·28 cites·12 claims
- 0594US7090847B1Mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2000·Granted Aug 15, 2006·69 cites·10 claims
- 0693US11859001B2IL12RB1-Binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jan 2, 2024·2 cites·14 claims
- 0793US8187596B1Method of treating asthma or allergy by administering an IL-33 receptor antibodyCHACKERIAN ALISSA A·Filed 2009·Granted May 29, 2012·52 cites·7 claims
- 0893US7501247B2Method of treating skin inflammationSCHERING CORP·Filed 2005·Granted Mar 10, 2009·31 cites·7 claims
- 0993US7422743B2Mammalian receptor protein DCRS5;methods of treatmentSCHERING CORP·Filed 2003·Granted Sep 9, 2008·38 cites·8 claims
- 1093US7183382B2Mammalian genes; related reagents and methodsSCHERING CORP·Filed 2003·Granted Feb 27, 2007·50 cites·22 claims
- 1193US6800460B1Mammalian cytokine complexesSCHERING CORP·Filed 2000·Granted Oct 5, 2004·38 cites·7 claims
- 1292US7820168B2Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17SCHERING CORP·Filed 2005·Granted Oct 26, 2010·16 cites·20 claims
- 1392US7754214B2Mammalian receptor protein DCRS5; methods of treatmentSCHERING CORP·Filed 2008·Granted Jul 13, 2010·14 cites·10 claims
- 1492US7560530B1IL-33 receptorSCHERING CORP·Filed 2007·Granted Jul 14, 2009·20 cites·4 claims
- 1592US7411041B2DCRS5 polypeptidesSCHERING CORP·Filed 2003·Granted Aug 12, 2008·30 cites·6 claims
- 1691US12077594B2IL2RG binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Sep 3, 2024·3 cites·22 claims
- 1791US7749718B2Method for raising or isolating an antibody to DCRS5SCHERING CORP·Filed 2008·Granted Jul 6, 2010·11 cites·4 claims
- 1891US7740848B2Method of treatment of skin inflammationSCHERING CORP·Filed 2008·Granted Jun 22, 2010·15 cites·7 claims
- 1990US10751412B2Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancerMERCK SHARP & DOHME·Filed 2016·Granted Aug 25, 2020·6 cites·28 claims
- 2090US7887806B2Mammalian receptor proteins DCRS5; method of treatmentSCHERING CORP·Filed 2010·Granted Feb 15, 2011·10 cites·14 claims
- 2189US7883695B2IL-12P40 and IL-B30 polypeptide complexSCHERING CORP·Filed 2006·Granted Feb 8, 2011·12 cites·3 claims
- 2289US7271248B2Human receptor proteins; related reagents and methodsSCHERING CORP·Filed 2004·Granted Sep 18, 2007·25 cites·12 claims
- 2389US6890734B2Nucleic acids encoding a cytokine receptor complexSCHERING CORP·Filed 2001·Granted May 10, 2005·16 cites·9 claims
- 2488US12012457B1IL23R binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jun 18, 2024·1 cites·42 claims
- 2587US12291572B2IL12 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted May 6, 2025·1 cites·12 claims
- 2687US12157773B2IL27RAlpha binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Dec 3, 2024·1 cites·53 claims
- 2786US12297281B2IL10RA binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted May 13, 2025·1 cites·16 claims
- 2886US7655761B2IL-17-like cytokine binding compounds and antibodiesSCHERING CORP·Filed 2007·Granted Feb 2, 2010·3 cites·3 claims
- 2986US7005501B2Purified mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2003·Granted Feb 28, 2006·6 cites·6 claims
- 3085US7776540B2Method of treating skin inflammationSCHERING CORP·Filed 2008·Granted Aug 17, 2010·7 cites·6 claims
- 3184US9970944B2Methods of modulating cytokine activity; related reagentsMERCK SHARP & DOHME·Filed 2014·Granted May 15, 2018·5 cites·8 claims
- 3283US7579440B2Mammalian cytokines; related reagentsSCHERING CORP·Filed 2004·Granted Aug 25, 2009·5 cites·3 claims
- 3383US7510853B2Nucleic acids encoding DCRS5SCHERING CORP·Filed 2003·Granted Mar 31, 2009·10 cites·9 claims
- 3483US7148330B2Binding compounds for IL-27SCHERING CORP·Filed 2001·Granted Dec 12, 2006·5 cites·14 claims
- 3582US8178095B2Method of treating skin inflammationKASTELEIN ROBERT A·Filed 2010·Granted May 15, 2012·7 cites·20 claims
- 3682US7569224B2Mammalian cytokines; receptors; related reagents and methodsSCHERING CORP·Filed 2005·Granted Aug 4, 2009·5 cites·9 claims
- 3782US7071308B2Cytokine receptorSCHERING CORP·Filed 2004·Granted Jul 4, 2006·13 cites·2 claims
- 3881US7670603B2Human DNAX toll-like receptor 4 proteins, related reagents and methodsSCHERING CORP·Filed 2008·Granted Mar 2, 2010·3 cites·3 claims
- 3981US6843987B2Mammalian cytokines; receptors; related reagents and methodsSCHERING CORP·Filed 2001·Granted Jan 18, 2005·8 cites·5 claims
- 4079US2025340656A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 4179US2025376528A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 4278US2024376217A1Il23r binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 4377US6326472B1Human receptor proteins; related reagents and methodsSCHERING CORP·Filed 1998·Granted Dec 4, 2001·42 cites·14 claims
- 4476US8691953B2Binding compounds for IL-27TIMANS JACQUELINE C·Filed 2011·Granted Apr 8, 2014·1 cites·8 claims
- 4576US8586035B2Use of IL-23 antagonists for treatment of infectionKOPF MANFRED·Filed 2008·Granted Nov 19, 2013·5 cites·12 claims
- 4676US8080392B2IL-D80 polynucleotidesTIMANS JACQUELINE C·Filed 2011·Granted Dec 20, 2011·1 cites·9 claims
- 4775US12209132B2Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 4875US2025019453A1Il2rb/il2g synthetic cytokinesSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 4975US2024166754A1Il12rb1-binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 5075US2025171548A1IL27RAlpha BINDING MOLECULES AND METHODS OF USESYNTHEKINE INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert A. Kastelein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →